Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 64, Issue 10, Pages -Publisher
WILEY
DOI: 10.1002/mnfr.202000015
Keywords
diabetic nephropathy; oxidative stress; isoflavones; renal inflammation
Categories
Funding
- Japan Society for the Promotion of Science (JSPS KAKENHI) [JP16K07734]
Ask authors/readers for more resources
Scope Dietary soy reportedly protects from diabetic nephropathy (DN), but its active components and mechanism of action remain unknown. Methods and results In this study, KKAy mice are fed three types of diet: Dietary soy isoflavones with soy protein (Soy-IP) diet, reduced isoflavones soy protein (RisoP), and oral administration of isoflavones aglycones (IsoAgc). Albuminuria and glycosuria are decreased only in the soy-IP group. The risoP group show reduced expansion of mesangial matrix and renal fibrosis, the IsoAgc group show renal anti-fibrotic and anti-inflammatory effects; however, these renal pathological changes are repressed in the soy-IP group, suggesting the distinct protective roles of soy protein or isoflavones in DN. The isoflavone genistein has a better inhibitory effect on the inflammatory response and cellular interactions in both mouse tubular cells and macrophages when exposed to high glucose and albumin (HGA). Genistein also represses HGA-induced activator protein 1 activation and reactive oxidases stress generation, accompanied by reduced NADPH oxidase (NOX) gene expression. Finally, diabetic mice show a decrease in lipid peroxidation levels in both plasma and urine, along with lower NOXs gene expression. Conclusion The data elucidate the detailed mechanism by which isoflavones inhibit renal inflammation and provide a potential practical adjunct therapy to restrict DN progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available